Formation of venous sinus thrombosis
Conditions
Interventions
Group 1:Darbiquant
Sponsors
Zhao Jianhua
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: (1) the age of 18 to 60 years old was not limited to the sex, which met the diagnostic criteria of cerebral venous thrombosis; (2) all the patients signed informed consent and were able to cooperate with the clinical follow-up observation.
Exclusion criteria
Exclusion criteria: (1) except those who have no relationship with CVST, such as brain trauma, malignant tumor, etc.; (2) due to other serious diseases, the expected survival time is less than 2 years; (3) those who do not agree to be included or disapprove of the follow-up; (4) stroke and transient ischemic attack within 6 months; (5) intracranial hemorrhage, gastrointestinal bleeding, bleeding in the urogenital system within 6 months; (6) warfarin and Darbiquin allergy; (7) severe liver and kidney diseases, chronic renal failure, Serum creatinine > 3.0 mg / d, aminotransferase more than three times the reference value; (8) other embolic diseases that require warfarin, Darbiquin; (9) long-term use of non-steroidal anti-inflammatory drugs; (10) use of anti-platelet drugs other than test drugs. Anticoagulants and thrombolytic drugs; (11) pregnancy and malignant neoplasms; (12) diagnosed or suspected hematological diseases (except); (13) platelet deficiency, blood plate < 100000ml.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| GCS scale;NHISS scale;mRS scale; | — |
Countries
China
Contacts
Public ContactZhao Jianhua
Department of Neurology, People's Hospital of Henan Province
Outcome results
None listed